• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Bayer

Kerendia
Pharma

FDA broadens label for Bayer's Kerendia to treat heart failure

The FDA has expanded the label of Bayer’s kidney disease drug Kerendia to include treatment of patients with two types of heart failure.
Kevin Dunleavy Jul 14, 2025 8:39am
Bayer Whippany

UK regulator approves Bayer's nonhormonal menopause drug

Jul 11, 2025 11:01am
LGBTQ Pride flag

GSK, Novo among Big Pharmas honoring 2025 LGBTQ+ Pride Month

Jun 26, 2025 3:31pm
Nubeqa

FDA approves use of Bayer's Nubeqa in all patients with mCSPC

Jun 4, 2025 11:38am
Bayer

Bayer weathers LOE for Xarelto with success of Kerendia, Nubeqa

May 13, 2025 11:25am
arrow back backwards u-turn turn around reverse

Bayer wins appeal in case of ‘warming’ market for Eylea launch

Apr 29, 2025 9:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings